Suppr超能文献

黄金岁月的奇亚万补汁,来自人体临床试验的证据基础薄弱。

Golden Ager Chyawanprash with Meager Evidential Base from Human Clinical Trials.

作者信息

Sharma Rohit, Kakodkar Pradnya, Kabra Atul, Prajapati Pradeep Kumar

机构信息

Department of Rasashastra and Bhaishajya Kalpana, Faculty of Ayurveda, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, Uttar Pradesh, India.

Department of Research, Dr D Y Patil Vidyapeeth, Pimpri, Pune, Maharashtra 411 018, India.

出版信息

Evid Based Complement Alternat Med. 2022 May 16;2022:9106415. doi: 10.1155/2022/9106415. eCollection 2022.

Abstract

Chyawanprash (CP) is one of the most revered, effective, and best-selling health supplements of Indian Ayurvedic system of medicine, which is high on the trust and health quotient among Indian consumers. CP is an ancient synergistic blend of around fifty (50) medicinal herbs, herbal extracts with jam-like consistency, traditionally used to improve respiratory health, strengthen the immune system, prevent recurrence of infections, and over the decades is known for its anti-inflammatory and antioxidant properties. With the recent growth of commercialization, this traditional preparation is gaining popularity across the world. Various pharma firms are engaged in its commercial production, and this recipe is easily available on market shelves, with a common brand name "Chyawanprash." The consumers generally pop up with some genuine queries or doubts regarding its usage and benefits. Though CP is well-trusted traditional preparation, however, limited scientific literature is available on understanding its clinical role. This critical review discusses the general consumer queries apropos its usage, critically analyzing the reported clinical studies, perspectives, and unmapped areas for future research.

摘要

查亚万补汁(CP)是印度阿育吠陀医学体系中最受尊崇、最有效的畅销健康补充剂之一,在印度消费者中享有很高的信任度和健康指数。CP是大约五十种药草与果酱状稠度的草本提取物的古老协同配方,传统上用于改善呼吸道健康、增强免疫系统、预防感染复发,几十年来一直以其抗炎和抗氧化特性闻名。随着近期商业化的发展,这种传统制剂在全球越来越受欢迎。多家制药公司从事其商业生产,这个配方在市场货架上很容易买到,常见品牌名为“查亚万补汁”。消费者通常会对其用法和益处提出一些真切的疑问或疑惑。尽管CP是备受信赖的传统制剂,但关于了解其临床作用的科学文献有限。这篇批判性综述讨论了与CP用法相关的一般消费者疑问,批判性地分析了已报道的临床研究、观点以及未来研究的未知领域。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0194/11387087/f40767e392fd/ECAM2022-9106415.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验